BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.17.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20261101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20261002T083000
DTEND;TZID=America/Vancouver:20261002T173000
DTSTAMP:20260828T174904Z
CREATED:20260828T174904Z
LAST-MODIFIED:20260828T174904Z
UID:41681-1790929800-1790962200@scienceinboston.com
SUMMARY:2nd Annual AI-Powered Innovation in Protein and Antibody Therapeutics
DESCRIPTION:Sino Biological invites you to the 2nd Annual AI-Powered Innovation in Protein and Antibody Therapeutics (AIPAT) Symposium\, a premier gathering of leading minds dedicated to shaping the future of biopharma discovery. \nThis year’s symposium features deep dives into machine learning models\, in silico screening\, and bridging the crucial gap between computationally designed proteins and real-world clinical application. \nJoin us at Le Méridien Cambridge on October 2nd to connect with industry pioneers\, spark new collaborations\, and help drive the next generation of AI-driven therapeutics. Enjoy great talks and devoted times for networking including a rooftop cocktail reception! \nFeatured Speakers include:\n-Dr. Diane Joseph-McCarthy – Executive Director\, Bioengineering Technology & Entrepreneurship Center; Professor of the Practice\, Biomedical Engineering & Chemistry\, Boston University; AIMBE fellow (Opening Keynote)\n-Dr. Abigail Lytton-Jean – Founding Scientific Director\, NanoFIB\, Koch Institute for Integrative Cancer Research at MIT (Scientific Keynote)\n-Dr. Matthew Bakalar – Head of Innovation Science\, Basecamp Research (Industry Keynote)\n-Dr. Daniel Bedinger – Senior Manager\, Field Application Science\, Carterra\n-Dr. Leo Wan – Founder and CEO\, Ranomics\n-Dr. Will Cao – Co-Founder & CEO\, Pando Bioscience\n-Devan Shah – Founder & CEO\, RNAV8 Bio\n-Allison Colhoart – Sr Principal Scientist of Drug Creation team\, Seismic Therapeutic \nWant to add your name to this list and win up to $2\,000? We invite researchers to submit abstracts for oral presentations. Submissions should focus on advancements in AI-driven protein and antibody therapeutics. All participants will receive free registration. Submission Deadline: August 31\, 2026 \nAwards:\n1st Place – $2000\n2nd Place – $1000\n3rd Place – $500
URL:https://scienceinboston.com/event/2nd-annual-ai-powered-innovation-in-protein-and-antibody-therapeutics/
LOCATION:Le Meridien Cambridge\, 20 Sidney St.\, Cambridge\, MA\, 02139\, United States
END:VEVENT
END:VCALENDAR